Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023
December 15 2022 - 6:59AM
Business Wire
Bristol Myers Squibb (NYSE:BMY) will announce results for the
fourth quarter of 2022 on Thursday, February 2, 2023. Company
executives will review financial results and address inquiries from
investors and analysts during a conference call beginning at 9:00
a.m. ET on the same date.
Investors and the general public are invited to listen to a live
webcast of the call at http://investor.bms.com. Investors and the
public can also access the live conference call by dialing in the
U.S. toll free 888-300-3045 or international +1 646-568-1027,
conference code: 3734085. Materials related to the call will be
available at http://investor.bms.com prior to the start of the
conference call.
A replay of the webcast will be available on
http://investor.bms.com approximately three hours after the
conference call concludes. A replay of the conference call will be
available beginning at 11:30 a.m. ET on February 2 through 11:30
a.m. ET on February 16, 2023, by dialing in the U.S. toll free
800-770-2030 or international +1 647-362-9199, conference code:
3734085.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221215005042/en/
Media: media@bms.com Investors:
Investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024